1. Home
  2. FTCI vs CGTX Comparison

FTCI vs CGTX Comparison

Compare FTCI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$3.85

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$0.97

Market Cap

102.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
CGTX
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
102.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
FTCI
CGTX
Price
$3.85
$0.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$10.80
$3.33
AVG Volume (30 Days)
106.5K
2.6M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.79
EPS
N/A
N/A
Revenue
$99,687,000.00
N/A
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.51
N/A
52 Week Low
$3.21
$0.55
52 Week High
$12.75
$3.83

Technical Indicators

Market Signals
Indicator
FTCI
CGTX
Relative Strength Index (RSI) 32.71 38.85
Support Level $3.30 $0.55
Resistance Level $5.40 $1.19
Average True Range (ATR) 0.41 0.09
MACD -0.12 -0.02
Stochastic Oscillator 6.70 14.80

Price Performance

Historical Comparison
FTCI
CGTX

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: